Literature DB >> 24186075

Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population.

Kiran Lata Sharma1, Anu Yadav, Annapurna Gupta, Sonam Tulsayan, Vijay Kumar, Sanjeev Misra, Ashok Kumar, Balraj Mittal.   

Abstract

CD44 is an important marker for cancer stem cells. Germline variants in CD44 gene have been associated with susceptibility to breast and nasopharyngeal carcinomas but no study in gallbladder cancer (GBC) has been done yet. The present study included 405 GBC patients and 200 healthy controls from North India. Tagger SNPs for CD44 were selected from the GIH population data. Genotyping was carried out by PCR-RFLP and Taqman probes. Statistical analysis was done by SPSS. Bonferroni correction was applied in subgroup analysis. Logistic regression analysis showed no individual association of CD44 polymorphisms with GBC risk. However, [CCAT] haplotype was associated with overall reduced risk of GBC [P = 0.04, odds ratios (OR) = 0.47]. Gender stratification revealed that [CCAT] and [TAGT] haplotypes were significantly associated with decreased risk in female GBC patients [P = 0.022, OR = 0.38; P = 0.011, OR = 0.17, respectively]. The CAAT haplotype was marginally associated with low GBC risk in patients with co-existing gallstones [P = 0.026, OR = 0.53]. The cancer risk was not further modified with tobacco usage or age of onset. In silico analysis showed change in transcriptional regulation of selected SNPs. This study reports an important role of CD44 haplotypes with reduced risk of GBC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24186075     DOI: 10.1007/s13277-013-1340-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  16 in total

1.  CD44: a cancer stem cell-related biomarker with predictive potential for radiotherapy.

Authors:  Michael Baumann; Mechthild Krause
Journal:  Clin Cancer Res       Date:  2010-09-22       Impact factor: 12.531

2.  Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression.

Authors:  I Roa; J C Araya; M Villaseca; X De Aretxabala; P Riedemann; K Endoh; J Roa
Journal:  Gastroenterology       Date:  1996-07       Impact factor: 22.682

3.  Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer.

Authors:  Kiran L Sharma; Sanjeev Misra; Ashok Kumar; Balraj Mittal
Journal:  Liver Int       Date:  2012-05-24       Impact factor: 5.828

Review 4.  Carcinoma of the gallbladder.

Authors:  Sanjeev Misra; Arun Chaturvedi; Naresh C Misra; Indra D Sharma
Journal:  Lancet Oncol       Date:  2003-03       Impact factor: 41.316

5.  Polymorphisms of CD44 gene and nasopharyngeal carcinoma susceptibility in a Chinese population.

Authors:  Mang Xiao; Sunhong Hu; Lei Zhang; Jun Huang; Huifen Jiang; Xiujun Cai
Journal:  Mutagenesis       Date:  2013-07-24       Impact factor: 3.000

Review 6.  CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression.

Authors:  L Y Bourguignon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

7.  Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.

Authors:  Thomas Winder; Yan Ning; Dongyun Yang; Wu Zhang; Derek G Power; Pierre Bohanes; Armin Gerger; Peter M Wilson; Georg Lurje; Laura H Tang; Manish Shah; Heinz-Josef Lenz
Journal:  Int J Cancer       Date:  2011-02-11       Impact factor: 7.396

8.  CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma.

Authors:  Chengjian Shi; Rui Tian; Min Wang; Xin Wang; Jianxin Jiang; Zhifa Zhang; Xu Li; Zheng He; Weiqiang Gong; Renyi Qin
Journal:  Cancer Biol Ther       Date:  2010-12-01       Impact factor: 4.742

9.  Immunohistochemical study of microvessel density, CD44 (standard form), p53 protein and c-erbB2 in gallbladder carcinoma.

Authors:  Harikleia Kalekou; Dimosthenis Miliaras
Journal:  J Gastroenterol Hepatol       Date:  2004-07       Impact factor: 4.029

10.  CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations.

Authors:  Lan Jiang; Jieqiong Deng; Xun Zhu; Jian Zheng; Yonghe You; Na Li; Hongchun Wu; Jiachun Lu; Yifeng Zhou
Journal:  Breast Cancer Res       Date:  2012-07-12       Impact factor: 6.466

View more
  19 in total

1.  Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival.

Authors:  Anu Yadav; Annapurna Gupta; Neeraj Rastogi; Sushma Agrawal; Ashok Kumar; Vijay Kumar; Balraj Mittal
Journal:  Tumour Biol       Date:  2015-08-30

2.  Cluster of Differentiation 44 (CD44) Gene Variants: A Putative Cancer Stem Cell Marker in Risk Prediction of Bladder Cancer in North Indian Population.

Authors:  Archana Verma; Rakesh Kapoor; Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2016-05-21

3.  Exploring the diagnosis markers for gallbladder cancer based on clinical data.

Authors:  Lingqiang Zhang; Runchen Miao; Xiude Zhang; Wei Chen; Yanyan Zhou; Ruitao Wang; Ruiyao Zhang; Qing Pang; Xinsen Xu; Chang Liu
Journal:  Front Med       Date:  2015-07-15       Impact factor: 4.592

4.  Association of Wnt signaling pathway genetic variants in gallbladder cancer susceptibility and survival.

Authors:  Anu Yadav; Annapurna Gupta; Saurabh Yadav; Neeraj Rastogi; Sushma Agrawal; Ashok Kumar; Vijay Kumar; Sanjeev Misra; Balraj Mittal
Journal:  Tumour Biol       Date:  2015-12-29

5.  Genetic association between CD44 polymorphisms and chronic hepatitis B virus infection in a Chinese Han population.

Authors:  Fan Li; Qing Shao; Dong Ji; Bing Li; Guofeng Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Effect of CD44 gene polymorphisms on risk of transitional cell carcinoma of the urinary bladder in Taiwan.

Authors:  Wei-Chun Weng; Yu-Hui Huang; Shun-Fa Yang; Shian-Shiang Wang; Wu-Hsien Kuo; Chao-Wen Hsueh; Ching-Hsuan Huang; Ying-Erh Chou
Journal:  Tumour Biol       Date:  2015-12-12

7.  miR-365 inhibits the progression of gallbladder carcinoma and predicts the prognosis of Gallbladder carcinoma patients.

Authors:  Ze-Bin Jiang; Bing-Qiang Ma; Zongfeng Feng; Shao-Guang Liu; Peng Gao; Hui-Ting Yan
Journal:  Cell Cycle       Date:  2021-01-18       Impact factor: 4.534

8.  Functional Genetic Variations at the microRNA Binding-Site in the CD44 Gene Are Associated with Risk of Colorectal Cancer in Chinese Populations.

Authors:  Xiao-Min Wu; Hong-Guo Yang; Bo-An Zheng; Hong-Feng Cao; Zhi-Ming Hu; Wei-Ding Wu
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

9.  Association of CD44 Gene Polymorphism with Survival of NSCLC and Risk of Bone Metastasis.

Authors:  Yaosheng Liu; Haifeng Qing; Xiuyun Su; Cheng Wang; Zhou Li; Shubin Liu
Journal:  Med Sci Monit       Date:  2015-09-10

10.  Positive association between CD44 gene rs13347 C>T polymorphism and risk of cancer in Asians: a systemic review and meta-analysis.

Authors:  Jinan Shi; Yin Duan; Lei Pan; Xiaoxi Zhou
Journal:  Onco Targets Ther       Date:  2016-06-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.